Durapav en es it fr

Durapav Brand names, Durapav Analogs

Durapav Brand Names Mixture

  • No information avaliable

Durapav Chemical_Formula


Durapav RX_link


Durapav fda sheet

Durapav msds (material safety sheet)

Durapav Synthesis Reference

No information avaliable

Durapav Molecular Weight

339.385 g/mol

Durapav Melting Point

No information avaliable

Durapav H2O Solubility

No information avaliable

Durapav State


Durapav LogP


Durapav Dosage Forms


Durapav Indication

For the treatment of impotence

Durapav Pharmacology

Papaverine is a nonxanthine phosphodiesterase inhibitor for the relief of cerebral and peripheral ischemia associated with arterial spasm and myocardial ischemia complicated by arrhythmias. The main actions of Papaverine are exerted on cardiac and smooth muscle. Like qathidine, Papaverine acts directly on the heart muscle to depress conduction and prolong the refractory period. Papaverine relaxes various smooth muscles. This relaxation may be prominent if spasm exists. The muscle cell is not paralyzed by Papaverine and still responds to drugs and other stimuli causing contraction. The antispasmodic effect is a direct one, and unrelated to muscle innervation. Papaverine is practically devoid of effects on the central nervous system. Papaverine relaxes the smooth musculature of the larger blood vessels, especially coronary, systemic peripheral, and pulmonary arteries.

Durapav Absorption

No information avaliable

Durapav side effects and Toxicity

No information avaliable

Durapav Patient Information

No information avaliable

Durapav Organisms Affected

Humans and other mammals